Haemonetics Corp Announces Q1 Results for Quarter Ended June 27, 2026

What Happened
Haemonetics Corporation filed a Current Report on Form 8-K on August 6, 2026 (Item 2.02) to announce its financial results for the first quarter ended June 27, 2026. The company furnished a press release with those results as Exhibit 99.1 to the 8-K. The report was signed by President and CEO Christopher A. Simon.

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Quarter covered: First quarter ended June 27, 2026.
• Exhibit filed: Press release announcing the quarterly results (Exhibit 99.1); interactive XBRL cover page included (Exhibit 104).
• Authorized signatory: Christopher A. Simon, President and Chief Executive Officer.

Why It Matters
This 8-K signals Haemonetics has publicly released its latest quarterly earnings and operational results; investors should review the furnished press release (Exhibit 99.1) for specific figures on revenue, earnings, cash flow and any commentary on guidance or trends. The filing is a formal, timely disclosure of the company’s quarterly results under the Securities Exchange Act.